...
首页> 外文期刊>臨床血液 >Complex additional chromosomal abnormalities of del(5q), del(7q), and +22 in a patient with acute myelomonocytic leukemia carrying inv(16)
【24h】

Complex additional chromosomal abnormalities of del(5q), del(7q), and +22 in a patient with acute myelomonocytic leukemia carrying inv(16)

机译:患有急性骨髓细胞白血病携带INV(16)的患者中的Del(5Q),Del(7Q),Del(7Q)和+22的复杂额外的染色体异常

获取原文
获取原文并翻译 | 示例
           

摘要

A 37-year-old man with acute myelomonocytic leukemia (AML) M4E who exhibited the complex karyotype of 5q-, 7q-, and +22 in addition to inv(16), relapsed soon after complete remission. As previously reported, AML M4E carrying inv(16) is associated with a good prognosis, even when co-occurring with chromosomal abnormalities, which alone are considered to have poor outcome. Cytogenetic prognosis studies, such as CALGB or SWOG, have reported that certain additional chromosomal abnormalities or complex karyotypes might affect the prognosis of patients with AML M4E with inv(16). Our case suggests that, in general, AML M4E carrying inv(16) is in the favorable risk category, while cases with additional chromosomal abnormalities or complex karyotypes might be classified in the poor risk group and thus should be given additional clinical attention.
机译:一个37岁的男性,患有急性骨髓细胞白血病(AML)M4E,除了INV(16)外,还表现出5Q-,7Q-和+22的复杂核型,在完全缓解后立即复发。 如前所述,即使在与染色体异常共同发生的情况下,AML M4E携带INV(16)也与良好的预后有关,单独考虑具有较差的结果。 CALGB或SWOG等细胞遗传学预后研究报告说,某些额外的染色体异常或复杂的核型可能会影响AML M4e患者的预后(16)。 我们的案例表明,一般而言,AML M4E携带纲领(16)处于有利的风险类别,而具有额外染色体异常或复杂的核型或复杂的核型的病例可能会在较差的风险组中进行分类,因此应提供额外的临床关注。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号